All Posts

1. Core Features of OpenEvidence's Advertising Model Free Service to Attract Doctors : Rapidly accumulate doctor users by providing free,...

1. Superpower Model and Regional Limitations Superpower’s Model Superpower ( https://superpower.com ) is a U.S.-based health and...

This report presents a cutting-edge comparison of biomarker interpretation approaches between Superpower's technology (...

Report Date: July, 2025 Purpose: To provide companies in the embodied intelligent robotics industry with a holistic market...

Executive Summary The rapid advancement of artificial intelligence (AI) presents significant opportunities for Chinese enterprises to...

Background and Overview MedGemma is an open-source medical AI large-scale model developed by Google, built on the Gemma 3 architecture,...

Introduction As artificial intelligence (AI) technology advances rapidly, its applications in healthcare are gaining increasing...

Key Takeaways Research indicates  that digital biomarkers and artificial intelligence (AI) hold significant potential in healthcare,...

关键要点 研究表明 ，数字生物标志物和人工智能（AI）在医疗保健领域，特别是在长寿医学中，具有显著潜力，可能延长健康寿命，但需进一步验证。 证据倾向于 支持数字生物标志物在疾病监测、个性化治疗和临床试验中的应用，尤其在帕金森病和心血管疾病领域。 AI在长寿医学中的机会...

关键要点 历史发展 ：数字生物标志物概念自2010年起逐渐成形，依托智能手机和可穿戴设备的普及，研究和专利活动显著增加。 当前应用 ：主要用于疾病监测、个性化治疗和临床试验，特别是在帕金森病和心血管疾病等领域。 未来趋势...